|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Accounts receivable from affiliates | ||||||||||||||||||||
| Other receivables, net | ||||||||||||||||||||
| Money pool notes receivable | ||||||||||||||||||||
| Materials, supplies and fuel | ||||||||||||||||||||
| Regulatory assets, current | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Property, plant and equipment | ||||||||||||||||||||
| Less: accumulated depreciation and amortization | ||||||||||||||||||||
| Total property, plant and equipment, net | ||||||||||||||||||||
| Other assets: | ||||||||||||||||||||
| Regulatory assets, non-current | ||||||||||||||||||||
| Other assets, non-current | ||||||||||||||||||||
| Total other assets, non-current | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDER’S EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable to affiliates | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Money pool notes payable | ||||||||||||||||||||
| Notes payable to Parent | ||||||||||||||||||||
| Regulatory liabilities, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred credits and other liabilities: | ||||||||||||||||||||
| Deferred income tax liabilities, net | ||||||||||||||||||||
| Regulatory liabilities, non-current | ||||||||||||||||||||
| Benefit plan liabilities | ||||||||||||||||||||
| Other deferred credits and other liabilities | ||||||||||||||||||||
| Total deferred credits and other liabilities | ||||||||||||||||||||
| Stockholder’s equity: | ||||||||||||||||||||
| Common stock $1 par value; 50,000,000 shares authorized; 23,416,396 shares issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholder’s equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY | ||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Common Stock, Shares Authorized | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
Loading...
